Albassam H - Search Results

1

Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation.

Obaidullah AJ, Alanazi MM, Alsaif NA, Alanazi AS, Albassam H, Az A, Alwassil OI, Alqahtani AM, Tareq AM. Obaidullah AJ, et al. Among authors: albassam h. Evid Based Complement Alternat Med. 2022 Jan 31;2022:8037488. doi: 10.1155/2022/8037488. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35140801 Free PMC article.

2

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.

Alanazi MM, Eissa IH, Alsaif NA, Obaidullah AJ, Alanazi WA, Alasmari AF, Albassam H, Elkady H, Elwan A. Alanazi MM, et al. Among authors: albassam h. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1760-1782. doi: 10.1080/14756366.2021.1956488. J Enzyme Inhib Med Chem. 2021. PMID: 34340610 Free PMC article.

3

Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase.

Alsaif NA, Elwan A, Alanazi MM, Obaidullah AJ, Alanazi WA, Alasmari AF, Albassam H, Mahdy HA, Taghour MS. Alsaif NA, et al. Among authors: albassam h. Mol Divers. 2022 Aug;26(4):1915-1932. doi: 10.1007/s11030-021-10303-6. Epub 2021 Aug 30. Mol Divers. 2022. PMID: 34460053

4

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.

Alsaif NA, Taghour MS, Alanazi MM, Obaidullah AJ, Alanazi WA, Alasmari A, Albassam H, Dahab MA, Mahdy HA. Alsaif NA, et al. Among authors: albassam h. Bioorg Med Chem. 2021 Sep 15;46:116384. doi: 10.1016/j.bmc.2021.116384. Epub 2021 Aug 28. Bioorg Med Chem. 2021. PMID: 34479065

5

Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2.

Obaidullah AJ, Alanazi MM, Alsaif NA, Albassam H, Almehizia AA, Alqahtani AM, Mahmud S, Sami SA, Emran TB. Obaidullah AJ, et al. Among authors: albassam h. RSC Adv. 2021 May 19;11(29):18103-18121. doi: 10.1039/d1ra02885e. eCollection 2021 May 13. RSC Adv. 2021. PMID: 35480208 Free PMC article.

6

Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studies.

Albassam H, Mehta CH, Nayak UY. Albassam H, et al. J Biomol Struct Dyn. 2022;40(23):13218-13232. doi: 10.1080/07391102.2021.1984308. Epub 2021 Oct 4. J Biomol Struct Dyn. 2022. PMID: 34606425

7

Prostaglandin D₂-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants.

Elhassanny AEM, Ladin DA, Soliman E, Albassam H, Morris A, Kobet R, Thayne K, Burns C, Danell AS, Van Dross R. Elhassanny AEM, et al. Among authors: albassam h. Prostaglandins Other Lipid Mediat. 2019 Jun;142:9-23. doi: 10.1016/j.prostaglandins.2019.03.001. Epub 2019 Mar 8. Prostaglandins Other Lipid Mediat. 2019. PMID: 30858059

8

Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress.

Nadeem A, Al-Harbi NO, Ahmad SF, Al-Harbi MM, Alhamed AS, Alfardan AS, Assiri MA, Ibrahim KE, Albassam H. Nadeem A, et al. Among authors: albassam h. Int Immunopharmacol. 2020 Jun;83:106369. doi: 10.1016/j.intimp.2020.106369. Epub 2020 Mar 9. Int Immunopharmacol. 2020. PMID: 32163900

9

Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner.

Mohammed Saleem YI, Albassam H, Selim M. Mohammed Saleem YI, et al. Among authors: albassam h. Eur J Nutr. 2020 Jun;59(4):1607-1618. doi: 10.1007/s00394-019-02016-2. Epub 2019 Jun 8. Eur J Nutr. 2020. PMID: 31177307

10

Apoptosis mechanisms induced by 15d-PMJ₂ in HCT116 colon cancer cells: insights into CHOP10/TRB3/Akt signaling.

Albassam H, Ladin DA, Elhassanny A, Burns C, Van Dross-Anderson R. Albassam H, et al. Front Pharmacol. 2023 Nov 2;14:1283677. doi: 10.3389/fphar.2023.1283677. eCollection 2023. Front Pharmacol. 2023. PMID: 38026967 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page